NEC Group's blood testing service 'FonesVisuas' adopted by Royal Healthcare, a medical institution for high-net-worth individuals in Singapore
NQ Score
50/100
AI Summary (NQ-processed)
NEC's blood testing service adopted in Singapore.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Which medical institution in Singapore has adopted the FonesVisuas blood testing service?
- A: Royal Healthcare, a Singapore-based medical institution and a subsidiary of Sojitz Corporation, has adopted it.
- Q: What does the FonesVisuas service analyze to visualize the current state of the body?
- A: It analyzes proteins that change daily from a small amount of blood.
- Q: Which diseases can the FonesVisuas service predict the risk of developing?
- A: It predicts the risk of developing dementia, myocardial infarction, stroke, lung cancer, chronic kidney failure, and prostate cancer.
- Q: Where is Royal Healthcare located, and what kind of services does it provide?
- A: It is based in Novena, Singapore, and provides personalized, high-quality health checkup services.
- Q: What is NEC's future plan for the expansion of the FonesVisuas service?
- A: NEC intends to expand the sales of FonesVisuas overseas, with a focus on the APAC region.